Screening – a discussion in clinical preventive medicine Galit M Sacajiu MD MPH.

Slides:



Advertisements
Similar presentations
GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Advertisements

SCID Review Discussion. Decision Matrix Key Questions 1.This is the overarching question for the evidence review: Is there direct evidence that screening.
1 Mark Huffman, MD, MPH Northwestern University Feinberg School of Medicine Northwestern Memorial Hospital Healthy Transitions 21 November 2013 Blood Pressure.
†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.
1 Case-Control Study Design Two groups are selected, one of people with the disease (cases), and the other of people with the same general characteristics.
SCREENING FOR DISEASE Nigel Paneth. THREE KEY MEASURES OF VALIDITY 1.SENSITIVITY 2.SPECIFICITY 3.PREDICTIVE VALUE.
Hepatitis B: Epidemiology
Screening. Screening refers to the application of a test to people who are as yet asymptomatic for the purpose of classifying them with respect to their.
April 6, o What is cancer? o Cancer statistics o Cancer prevention and early detection o Cancer disparities o Cancer survivorship o Cancer research.
Colorectal cancer: How do we approach health disparities? Marta L. Davila, MD, FASGE University of Texas MD Anderson Cancer Center.
Prof. Wasantha Gunathunga.  Primary  Secondary  Tertiary.
Haley Hyde Jessica Fordham Jena Hamm  Colorectal cancer is a leading cause of cancer related deaths every year.  150,000 Americans will be diagnosed.
Geriatric Health Maintenance: Cancer Screening Linda DeCherrie, MD Geriatric Fellow Mount Sinai Hospital.
Principles of Epidemiology Lecture 12 Dona Schneider, PhD, MPH, FACE
Screening Sherine Shawky, MD, Dr.PH Assistant Professor Public Health King Abdulaziz University College of Medicine
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
Turning Data into Action for Colorectal Cancer November 17, 2014 Jessica Shaffer, Director, Maine CDC Colorectal Cancer Control Program
Stage-specific survival of screen-detected versus clinically diagnosed colorectal cancer - evidence from the FOBT screening trials- Iris Lansdorp-Vogelaar.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
The Nature of Disease.
Multiple Choice Questions for discussion
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Thomas B. Newman, MD, MPH Andi Marmor, MD, MSEd October 21, 2010.
EPIB-591 Screening Jean-François Boivin 29 September
Screening Introduction to Primary Care:
Lecture 4: Assessing Diagnostic and Screening Tests
INCIDENCE AND SURVIVAL TRENDS OF COLORECTAL CANCER FROM 2002 TO 2011 BE Ansa; E Alema-Mensah; MD Claridy; JQ Sheats; B Fontenot, and SA Smith Georgia Regents.
1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.
Cancer Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Principles and Predictive Value of Screening. Objectives Discuss principles of screening Describe elements of screening tests Calculate sensitivity, specificity.
Reliability of Screening Tests RELIABILITY: The extent to which the screening test will produce the same or very similar results each time it is administered.
1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.
“The African American Prostate Cancer Crisis in Numbers”
Smear negative TB and HIV: urgent research priorities to inform a rolling global policy Haileyesus Getahun, MD, MPH, PhD Stop TB Department WHO/HQ.
Dr K N Prasad Community Medicine
Screening and Diagnostic Testing Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego State University.
1 SCREENING. 2 Why screen? Who wants to screen? n Doctors n Labs n Hospitals n Drug companies n Public n Who doesn’t ?
Module 2: Quality and Quality Measures The degree to which health services for individuals and populations increase the likelihood of desired health outcomes.
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
Data Sources-Cancer Betsy A. Kohler, MPH, CTR Director, Cancer Epidemiology Services New Jersey Department of Health and Senior Services.
Nies and Nies and McEwen: Chapter 4: ATI: Chapter 3 Epidemiology.
Screening Puja Myles
Introduction to Healthcare and Public Health in the US The Evolution and Reform of Healthcare in the US Lecture b This material (Comp1_Unit9b) was developed.
Evaluating Screening Programs Dr. Jørn Olsen Epi 200B January 19, 2010.
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
Screening and its Useful Tools Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
Colorectal Cancer Screening Colorectal Cancer Screening VT SGNA Conference VT SGNA Conference October 24, 2015 October 24, 2015 Lynn Butterly, MD Lynn.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
12/12/2009Dr. Salwa Tayel1 Comunicación y Gerencia.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
Chapter 7: Epidemiology of Chronic Diseases. “The Change You Like to See….” (1 of 3) Chronic diseases result from prolongation of acute illness. – With.
Copyright © 2008 Delmar. All rights reserved. Chapter 4 Epidemiology and Public Health Nursing.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
Screening System for Hypertension and Diabetes at Primary Care Level
Cancer prevention and early detection
Clinical Epidemiology
Colorectal Cancer Screening Guidelines
The Burden of Colorectal Cancer in Arkansas
Principles of Epidemiology E
More Ontarians need to be screened for colorectal cancer (Sept. 2012)
Prepared by staff in Prevention and Cancer Control.
Definition of Cancer Screening
Dr. Tauseef Ismail Assistant Professor Dept of C Med. KGMC
How do we delay disease progress once it has started?
Citation: Cancer Care Ontario
Evidence Based Diagnosis
Presentation transcript:

Screening – a discussion in clinical preventive medicine Galit M Sacajiu MD MPH

What is Screening The application of a test to a presymptomatic individuals to classify them with respect to their likelihood of developing a particular disease

Why to screen Decrease morbidity and mortality at the individual level Decrease public health cost Decrease infectivity within a population Personal wish for knowledge

What Diseases need to be screened? Serious Availability of treatment Treatment before symptoms ensue is more beneficial than after disease manifested High prevalence

Early diagnosis and Natural History of Disease Biological onset Early Diagnosis Possible Usual clinical diagnosis Outcome Recovery disability Death CP 1 CP 2 CP 3 T I M E Adapted from Clinical Epidemiology, Sacket, et. al.

Screening Tests Inexpensive Easy to administer Impose minimal discomfort Statistically sound: Reliable Valid Reproducible

Statistically sound: Reliable & Reproducible The extent to which the screening test will produce the same or very similar results each time it is administered.

Statistically sound: Valid Validity is the ability of a test to indicate which individuals have the disease and which do not. And it can be measured by sensitivity and specificity Sensitivity is the ability of the test to identify correctly those who have the disease Specificity is the ability of the test to identify correctly those who do not have the disease

Calculate Validity- sensitivity & specificity Sensitivity= A/A+C Specificity = D/D+B

Pay attention to Biases

And another bias… Length Bias

Screening recommendations Canadian Task Force US Task Force providers/guidelines- recommendations/index.html

Examples Chronic Disease - Hypertension Infectious Disease – HIV Malignancy – Colonoscopy

We recommend blood pressure measurement at all appropriate primary care visitsi,ii). (Strong recommendation; moderate quality evidence)iii We recommend that blood pressure be measured according to the current techniques described in the Canadian Hypertension Education Program (CHEP) recommendations for office and out-of-office (ambulatory) blood pressure measurement). (Strong recommendation; moderate quality evidence) For people who are found to have an elevated blood pressure during screening, the CHEP criteria for assessment and diagnosis of hypertension should be applied to determine whether the patient meets diagnostic criteria for hypertension. (Strong recommendation; moderate quality evidence) Canadian Task Force

The HIV Screening. Standard Care. program developed by the Centers for Disease Control and Prevention (CDC) gives primary care providers new tools to help ensure all patients are tested for HIV at least once in their life. Of the more than 1.1 million people in the United States estimated to be living with HIV, approximately 20% are unaware of their HIV status. Center for Disease Control and prevention

Colon Cancer Is the condition Serious? Is its prevalence/incidence high enough? Colorectal cancer is a major cause of morbidity and mortality throughout the world. It accounts for over 9% of all cancer incidence. It is the third most common cancer worldwide and the fourth most common cause of death. 1. World Health Organization Cancer Incidence in Five Continents. Lyon: The World Health Organization and The International Agency for Research on Cancer; World Cancer Research Fund and American Institute for Cancer Research Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research; Boyle P, Langman J S. ABC of colorectal cancer: Epidemiology. BMJ. 2000;321(7264):805–808

Colon Cancer Is there a “critical Period”?...a detectable asymptomatic phase during which therapy decreases morbidity or mortality? (and is superior to waiting till symptoms appear?) Colorectal cancer survival is highly dependent upon stage of disease at diagnosis, and typically ranges from a 90% 5-year survival rate for cancers detected at the localized stage; 70% for regional; to 10% for people diagnosed for distant metastatic cancer. In general, the earlier the stage at diagnosis, the higher the chance of survival. Jemal A, Clegg L X, Ward E, et al. Annual report to the nation on the status of cancer, , with a special feature regarding survival. Cancer. 2004;101(1):3–27.

Colon Cancer Screening Is the test inexpensive? (monetary/ time) Is the test reproducible with low observer variability? Regular screening, beginning at age 50, is the key to preventing colorectal cancer. 1 The U.S. Preventive Services Task Force (USPSTF) recommends screening for colorectal cancer using high- sensitivity fecal occult blood testing, sigmoidoscopy, or colonoscopy beginning at age 50 years and continuing until age 75 years. 1 1

Colon cancer CBS Harry Smith's Live Colonoscopy 07l0c48Rs

Colon cancer Is treatment acceptable and available?

Stage (TNM Staging Criteria) Standard Treatment Options Stage 0 Colon CancerSurgery Stage I Colon CancerSurgery Stage II Colon CancerSurgery Stage III Colon CancerSurgery Adjuvant chemotherapy Standard Treatment Options for Stages 0–III Colon Cancer

Take Home Points Is the condition Serious? Is it common? Is its prevalence/incidence high enough? Is there a “critical Period”?...a detectable asymptomatic phase during which therapy decreases morbidity or mortality? (and is superior to waiting till symptoms appear?) Is treatment acceptable and available? Is the test sensitive/specific? Is the test inexpensive? (monetary/ time) Is the test reproducible with low observer variability?

Merci